Level Biotechnology

Level Biotechnology EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Level Biotechnology (3118.TWO) as of Oct 19, 2026 is 17.88. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 16.63 — a change of 7.53% (higher).

EV/OCF

17.88

YoY

7.53%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Level Biotechnology is 2025 17.88 . EV/OCF (Enterprise Value to Operating Cash Flow) of Level Biotechnology was 2024 16.63 . It decreases by 7.53% higher compared to the previous year.

The Level Biotechnology EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
39.82 TWD
Jan 1, 2019
9.78 TWD
Jan 1, 2020
8.43 TWD
Jan 1, 2021
3.89 TWD
Jan 1, 2022
9.46 TWD
Jan 1, 2023
8.72 TWD
Jan 1, 2024
16.63 TWD
Jan 1, 2025
17.88 TWD
The Level Biotechnology EV/OCF history
YEAREV/OCFYoY
17.88+7.53%
16.63+90.75%
8.72-7.79%
9.46+143.15%
3.89-53.87%
8.43-13.79%
9.78-75.44%
39.82+166.27%
14.95+62.47%
9.20+24.20%
7.41+0.47%
7.38—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Level Biotechnology Stock analysis

What does Level Biotechnology do? Level Biotechnology Inc is a company based in Taipei, Taiwan, operating within the Health Care sector. It went public on September 10, 2004, with its ticker symbol 3118.TWO and ISIN TW0003118006. The company provides biotechnological services, focusing on products such as cell culture series, immune protein series, gene nucleic acid and molecular biology series, and instrument series. Additionally, Level Biotechnology offers preclinical testing services, including genetic toxicity testing, general toxicology testing, reproductive toxicology testing, pharmacokinetic testing, and biocompatibility testing. The company's website is https://www.level.com.tw/index_tw.php. Level Biotechnology operates primarily in the domestic market, serving clients within Taiwan. It is headquartered in Taipei, New Taipei, as stated in the provided information. The company's services and products are designed to support research and development in the biotechnology and health care fields. No additional details about founding year, key personnel, acquisitions, or specific financial figures are provided in the given data. The company's activities are centered around delivering specialized biotechnological solutions to its market. Level Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Level Biotechnology stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Level Biotechnology is 17.88 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Level Biotechnology changed from 16.63 to 17.88, representing a 7.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Level Biotechnology since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Level Biotechnology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Level Biotechnology

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Level Biotechnology